Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Ovarian Neoplasms 8Neuroblastoma 8Carcinoma, Ovarian Epithelial 6Uterine Cervical Neoplasms 4Fallopian Tube Neoplasms 4Sarcoma 3Leukemia 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Brenner Tumor 2Brain Neoplasms 2Wilms Tumor 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Pleuropulmonary blastoma 1Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Meningeal Carcinomatosis 1Medulloblastoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1

Interventions

Vincristine 6Radiotherapy 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Gemcitabine 4Cisplatin 4Rituximab 3Methotrexate 3Cytarabine 3Crizotinib 3ibritumomab tiuxetan 2Vinorelbine 2Methylprednisolone 2Etoposide 2Drug Therapy 2Dexamethasone 2merphos 1liposomal amphotericin B 1ixabepilone 1imetelstat 1Whole-Body Irradiation 1Watchful Waiting 1Vinblastine 1VAP-cyclo protocol 1Topotecan 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Anaplastic × Topotecan × Clear all
NCT01606878 2024-01-05

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Children's Oncology Group

Phase 1 Completed
46 enrolled 24 charts
CNSLymphoid

Neuroblastoma, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡